Surgery for Prostate Cancer (Date: 2/3/2023)
Poly-Metastatic Hormone-Sensitive Disease (Date: 1/31/2023)
Radiotherapy for Localized Prostate Cancer (Date: 1/28/2023)
Managing Prostate Cancer Treatment Side Effects (Date: 1/27/2023)
ADT-Resistant Metastatic Prostate Cancer (Date: 1/24/2023)
Evaluation and Management of PSA Recurrence after Definitive Treatment of Localized Prostate Cancer (Date: 1/18/2023)
Focal Prostate Cancer Ablation: A Less Morbid Alternative to Surgery and Radiation (Date: 1/17/2023)
Androgen Deprivation Therapy and Prostate Cancer (Date: 1/15/2023)
Prostate Cancer: Diet and Exercise (Date: 1/14/2023)
Prostate Cancer Genetics and Genomics (Date: 1/13/2023)
Prostate Cancer Active Surveillance (Date: 1/10/2023)
Race and Prostate Cancer Disparities (Date: 1/8/2023)
Prostate Cancer Overview (Date: 1/7/2023)
ADT Resistant Metastatic Prostate Cancer (mCRPC) - 2021 Prostate Cancer Patient Conference (Date: 8/6/2021)
Oligometastatic Disease (Date: 8/4/2021)
ADT Resistant Non-Metastatic Prostate Cancer (nmCRPC) - 2021 Prostate Cancer Patient Conference (Date: 8/3/2021)
PSMA Targeting for Treatment of Advanced Prostate Cancer - 2021 Prostate Cancer Patient Conference (Date: 8/2/2021)
Untreated Metastatic Prostate Cancer - 2021 Prostate Cancer Patient Conference (Date: 8/1/2021)
PSA Recurrence Risk Assessment - 2021 Prostate Cancer Patient Conference (Date: 7/30/2021)
Localized Prostate Cancer: Radiation - 2021 Prostate Cancer Patient Conference (Date: 7/29/2021)
Click to Subscribe
